WINDGAP MEDICAL, INC.

Profile

Company Names

WINDGAP MEDICAL, INC.

Addresses

200 DEXTER AVENUE, SUITE 270, WATERTOWN, MA 02472

5 MIDDLESEX AVENUE, SUITE 400, SOMERVILLE, MA 02145

Phone Numbers

(617) 440-3311

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$76,712,778.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-11-06 
$12,650,000.00 
$17,250,000.00 
$4,600,000.00 
Debt 
7
2021-08-27 
$39,151,781.00 
$42,169,754.00 
$3,017,973.00 
Equity 
6
2020-02-28 
$360,500.00 
$2,000,000.00 
$1,639,500.00 
Debt 
5
2019-01-02 
$12,151,193.00 
$39,017,359.00 
$26,866,166.00 
Equity 
4
2017-05-01 
$3,794,089.00 
$4,000,000.00 
$205,911.00 
Debt 
3
2016-03-25 
$2,889,618.00 
$4,000,000.00 
$1,110,382.00 
Debt 
2
2015-05-14 
$4,221,097.00 
$4,500,000.00 
$278,903.00 
Equity 
1
2014-04-09 
$1,494,500.00 
$2,717,500.00 
$1,223,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRENT 
 
BUCHINE 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
CADIGAN 
EXECUTIVE OFFICER
JOHN 
 
CONLEY 
DIRECTOR
JASON 
 
DURKIN 
EXECUTIVE OFFICER
J. 
MELVILLE 
ENGLE 
DIRECTOR
RICHARD 
 
GABRIEL 
DIRECTOR
TIM 
 
KROCHUK 
EXECUTIVE OFFICER, DIRECTOR
TIMOTHY 
 
KROCHUK 
DIRECTOR
AARON 
 
MANN 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
MCKEE 
DIRECTOR
MAX 
 
MEEHAN 
EXECUTIVE OFFICER
MICHAEL 
 
SAMAR 
EXECUTIVE OFFICER
CHRISTOPHER 
 
STEPANIAN 
EXECUTIVE OFFICER, DIRECTOR
ANTHONY 
 
WATSON 
EXECUTIVE OFFICER
JOHN 
READING 
WILSON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-11-06 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2023-11-06 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-02 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-01 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-03-25 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-14 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-05-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#